Dealings In Securities By Directors: Allotment Of Shares AfroCentric Investment Corporation Limited (Incorporated in the Republic of South Africa) (Registration number 1988/000570/06) JSE Code: ACT ISIN: ZAE000078416 (“AfroCentric” or “the Company”) DEALINGS IN SECURITIES BY DIRECTORS: ALLOTMENT OF SHARES Shareholders are referred to the announcement released on SENS on 11 October 2013 wherein shareholders were advised of the allotments to be made to the participating executives following the achievement of profit warranties pursuant to the 2008 Acquisition Agreement, subsequent to the acquisition by AfroCentric of Lethimvula Investments Limited (“the Acquisition”), now known as AfroCentric Health (Pty) Limited. Further to the allotments on 14 November 2013 and announced on SENS on 15 November 2013, in compliance with paragraphs 3.63 to 3.74 of the Listings Requirements of the JSE Limited shareholders are hereby advised of the following additional dealings in securities of AfroCentric which are also pursuant to the Acquisition: Name of director Vijay Pillay Executive Director of Medscheme Holdings (Pty) Limited, Designation a major subsidiary of the Company Date of transaction 15 December 2016 Off market receipt of new ordinary shares in AfroCentric Nature of transaction pursuant to the second tranche share payment Class of security Ordinary shares Number of securities 196 782 Deemed price* per security R5.91 Value of transaction R1 162 981.62 Nature of interest Direct Beneficial Clearance obtained Yes Name of director Timothy Mako Rametse Designation Executive Director of AfroCentric Health (Pty) Limited and Medscheme Holdings (Pty) Limited, which are major subsidiaries of the Company Date of transaction 15 December 2016 Nature of transaction Off market receipt of new ordinary shares in AfroCentric pursuant to the second tranche share payment Class of security Ordinary shares Number of securities 195 646 Deemed price* per security R5.91 Value of transaction R1 156 267.86 Nature of interest Direct Beneficial Clearance obtained Yes Name of director Lee Recardoe Callakoppen Designation Executive Director of AfroCentric Health (Pty) Limited and Medscheme Holdings (Pty) Limited, which are major subsidiaries of the Company Date of transaction 15 December 2016 Nature of transaction Off market receipt of new ordinary shares in AfroCentric pursuant to the second tranche share payment Class of security Ordinary shares Number of securities 494 764 Deemed price* per security R5.91 Value of transaction R2 924 055.24 Nature of interest Direct Beneficial Clearance obtained Yes Name of director Kevin Michael Aron Designation Executive Director of Medscheme Holdings (Pty) Limited, a major subsidiary of the Company Date of transaction 15 December 2016 Nature of transaction Off market receipt of new ordinary shares in AfroCentric pursuant to the second tranche share payment Class of security Ordinary shares Number of securities 631 414 Deemed price* per security R5.91 Value of transaction R3 731 656.74 Nature of interest Direct Beneficial Clearance obtained Yes *The deemed price is the closing share price of AfroCentric on 15 December 2016. There is no further outstanding payment in respect of the second tranche share payment. Johannesburg 21 December 2016 Sponsor Sasfin Capital (a division of Sasfin Bank Limited) Date: 21/12/2016 03:08:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.